FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3205499587> ?p ?o ?g. }

• W3205499587 endingPage "175628642110500" @default.
• W3205499587 startingPage "175628642110500" @default.
• W3205499587 abstract "Malformation of cortical development (MCD) is one of the most common causes of pharmacoresistant epilepsy. Improving the knowledge of antiseizure medications (ASMs) treatment response in epileptic patients with MCD is crucial for optimal treatment options, either pharmacological therapy or non-pharmacological intervention.To investigate the patterns of medical treatment outcome and the predictors for seizure freedom (SF) with ASM regimens in epilepsy caused by MCD.The epileptic patients with MCD were consecutively enrolled from March 2013 to June 2019. SF was defined as no seizures for at least 12 months or three times the longest pretreatment inter-seizure interval, whichever was longer. Outcomes were classified into three patterns: pattern A: patients achieved SF at one point and remained so throughout follow-up; pattern B: patients' seizures fluctuated between periods of SF and relapse; pattern C: SF never attained. The terminal SF was defined if the patients remained SF at the last follow-up visit.A total of 164 epileptic patients with MCD were included. Pattern A was observed in 22, pattern B in 42, and pattern C in 100 patients. SF was ever achieved in 64 (pattern A and B) patients. Twenty-nine patients had terminal SF after a median follow-up time of 4.3 years. With continuing ASM treatment, seizure relapse risk was very low after a 5-year seizure-free period. The pretreatment seizure frequency was the only independent predictor for pattern A and seizure relapse. Sodium channel blockers monotherapy (33.8%) was more effective than levetiracetam (4.5%) in rendering SF in the initial ASM regimen.Medical treatment can be successful in a minority of epileptic patients with MCD, and pretreatment seizure frequency helps to predict the treatment outcome. An unequal efficacy of ASMs in epilepsy caused by MCD suggests etiological evaluation is vital in the management of focal epilepsy." @default.
• W3205499587 created "2021-10-25" @default.
• W3205499587 creator A5010953370 @default.
• W3205499587 creator A5012285468 @default.
• W3205499587 creator A5017424675 @default.
• W3205499587 creator A5019405663 @default.
• W3205499587 creator A5031103199 @default.
• W3205499587 creator A5034955456 @default.
• W3205499587 creator A5044622075 @default.
• W3205499587 creator A5056129834 @default.
• W3205499587 creator A5058776588 @default.
• W3205499587 creator A5060664791 @default.
• W3205499587 creator A5063681878 @default.
• W3205499587 creator A5067331026 @default.
• W3205499587 creator A5074494339 @default.
• W3205499587 creator A5078204891 @default.
• W3205499587 creator A5083128057 @default.
• W3205499587 date "2021-01-01" @default.
• W3205499587 modified "2023-10-13" @default.
• W3205499587 title "Response to antiseizure medications in epileptic patients with malformation of cortical development" @default.
• W3205499587 cites W1519576347 @default.
• W3205499587 cites W1647665937 @default.
• W3205499587 cites W1762149727 @default.
• W3205499587 cites W1900191643 @default.
• W3205499587 cites W1920696238 @default.
• W3205499587 cites W1966792725 @default.
• W3205499587 cites W1974809694 @default.
• W3205499587 cites W2000933955 @default.
• W3205499587 cites W2015420875 @default.
• W3205499587 cites W2019178697 @default.
• W3205499587 cites W2039600900 @default.
• W3205499587 cites W2049800034 @default.
• W3205499587 cites W2069534738 @default.
• W3205499587 cites W2074904157 @default.
• W3205499587 cites W2090276138 @default.
• W3205499587 cites W2095969890 @default.
• W3205499587 cites W2100850001 @default.
• W3205499587 cites W2105727230 @default.
• W3205499587 cites W2108997250 @default.
• W3205499587 cites W2111774221 @default.
• W3205499587 cites W2124586903 @default.
• W3205499587 cites W2138304538 @default.
• W3205499587 cites W2141807669 @default.
• W3205499587 cites W2231975197 @default.
• W3205499587 cites W2474485063 @default.
• W3205499587 cites W2515101847 @default.
• W3205499587 cites W2591806149 @default.
• W3205499587 cites W2594644573 @default.
• W3205499587 cites W2612904569 @default.
• W3205499587 cites W2761875494 @default.
• W3205499587 cites W2798181793 @default.
• W3205499587 cites W2800861087 @default.
• W3205499587 cites W2893836576 @default.
• W3205499587 cites W2895730479 @default.
• W3205499587 cites W2903229176 @default.
• W3205499587 cites W2920332929 @default.
• W3205499587 cites W2985696593 @default.
• W3205499587 doi "https://doi.org/10.1177/17562864211050027" @default.
• W3205499587 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8521419" @default.
• W3205499587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34671424" @default.
• W3205499587 hasPublicationYear "2021" @default.
• W3205499587 type Work @default.
• W3205499587 sameAs 3205499587 @default.
• W3205499587 citedByCount "3" @default.
• W3205499587 countsByYear W32054995872022 @default.
• W3205499587 countsByYear W32054995872023 @default.
• W3205499587 crossrefType "journal-article" @default.
• W3205499587 hasAuthorship W3205499587A5010953370 @default.
• W3205499587 hasAuthorship W3205499587A5012285468 @default.
• W3205499587 hasAuthorship W3205499587A5017424675 @default.
• W3205499587 hasAuthorship W3205499587A5019405663 @default.
• W3205499587 hasAuthorship W3205499587A5031103199 @default.
• W3205499587 hasAuthorship W3205499587A5034955456 @default.
• W3205499587 hasAuthorship W3205499587A5044622075 @default.
• W3205499587 hasAuthorship W3205499587A5056129834 @default.
• W3205499587 hasAuthorship W3205499587A5058776588 @default.
• W3205499587 hasAuthorship W3205499587A5060664791 @default.
• W3205499587 hasAuthorship W3205499587A5063681878 @default.
• W3205499587 hasAuthorship W3205499587A5067331026 @default.
• W3205499587 hasAuthorship W3205499587A5074494339 @default.
• W3205499587 hasAuthorship W3205499587A5078204891 @default.
• W3205499587 hasAuthorship W3205499587A5083128057 @default.
• W3205499587 hasBestOaLocation W32054995871 @default.
• W3205499587 hasConcept C118552586 @default.
• W3205499587 hasConcept C126322002 @default.
• W3205499587 hasConcept C187212893 @default.
• W3205499587 hasConcept C2777332695 @default.
• W3205499587 hasConcept C2778186239 @default.
• W3205499587 hasConcept C2778201146 @default.
• W3205499587 hasConcept C42219234 @default.
• W3205499587 hasConcept C71924100 @default.
• W3205499587 hasConceptScore W3205499587C118552586 @default.
• W3205499587 hasConceptScore W3205499587C126322002 @default.
• W3205499587 hasConceptScore W3205499587C187212893 @default.
• W3205499587 hasConceptScore W3205499587C2777332695 @default.
• W3205499587 hasConceptScore W3205499587C2778186239 @default.
• W3205499587 hasConceptScore W3205499587C2778201146 @default.
• W3205499587 hasConceptScore W3205499587C42219234 @default.

• next